From Endothelial Progenitor Cells to Tissue Engineering: How Far Have We Come?

Investor logo
Investor logo

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Informatics. Official publication website can be found on muni.cz.
Authors

ŠALINGOVÁ Barbara MADARÁSOVÁ Martina STEJSKAL Stanislav TESAŘOVÁ Lenka ŠIMARA Pavel KRONTORÁD KOUTNÁ Irena

Year of publication 2014
Type Article in Periodical
Magazine / Source Journal of Stem Cell Research & Therapy
MU Faculty or unit

Faculty of Informatics

Citation
Web Journal of Stem Cell Research and Therapy
Doi http://dx.doi.org/10.4172/2157-7633.1000185
Field Genetics and molecular biology
Keywords EPC; In vitro vascularization; Small-diameter vessels
Description Cardiovascular disease has become the leading cause of death in high income countries worldwide and the available treatment is not able to provide a complete recovery. Tissue engineering offers a possibility to construct autologous vein replacements for surgery. In this review we summarize approaches leading to artificial vascular graft construction. We discuss biomaterials currently in use, various drug delivery systems and the most appropriate cell cultures for vein engineering. Despite the progress in biomaterials and drug delivery systems, generating a suitable tissue microenvironment and selection of the appropriate cell population for graft seeding remains a major challenge. Here we focus on endothelial progenitor stem cells as the most suitable cell type for vascular graft construction. We discuss its sources, isolation techniques and differentiation procedures.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.